Remove Antibody Remove FDA Approval Remove Laboratory Informatics
article thumbnail

4 Life Science Trends To Pay Attention To in 2021

XTalks

These include monoclonal antibody drugs, which are attractive therapeutic agents owing to their targeted specificity. Eli Lilly’s bamlanivimab and Regeneron’s monoclonal antibody cocktail REGEN-COV2 which consists of two monoclonal antibodies, casirivimab and imdevimab, were approved in 2020 for use in the treatment of COVID-19 patients.